[Morphological characteristics of slowly and rapidly progressing human bladder papillomas]

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Transitional cell papillomas (TP) of the urinary bladder are neoplasms requiring accurate prognostic classification.
• Distinguishing between slow and rapid progression is crucial for patient management and treatment outcomes.

Purpose of the Study:

• To categorize transitional cell papillomas (TP) into distinct prognostic groups based on clinical and pathological features.
• To identify specific histological and ultrastructural markers differentiating slow-progressing from rapidly progressing TP.
• To evaluate the long-term clinical implications, including recurrence and malignancy rates, associated with each TP subtype.

Main Methods:

• Analysis of 477 transitional cell papillomas (TP) with classification based on treatment outcomes and clinicopathological features.
• Histological examination focusing on epithelial thickness, mitotic index, and cellular differentiation.
• Ultrastructural analysis of basal and intermediate epithelial cells.
• Long-term follow-up (10 years) to assess recurrence and malignancy rates post-excision.

Main Results:

• TP were divided into slowly progressing (10.9%) and rapidly progressing (89.1%) groups.
• Rapidly progressing TP exhibited significantly higher rates of recurrence (5-fold) and malignancy (12-fold) over 10 years post-excision.
• Histological differences included size, base width, epithelial thickness (7-8 layers vs. >8 layers), and mitotic index (3-4x normal vs. 0.5-1.0%).
• Ultrastructural differentiation of basal and intermediate cells was preserved in slow progressors but sometimes effaced in rapid progressors, despite the absence of cellular atypia.

Conclusions:

• Subdividing transitional cell papillomas (TP) into slow and rapid progression categories is clinically significant.
• This classification improves disease prognosis and aids in more accurate statistical recording.
• Identifying rapidly progressing TP allows for targeted surveillance and management strategies to mitigate adverse outcomes.